Skip to main
MODV
MODV logo

ModivCare (MODV) Stock Forecast & Price Target

ModivCare (MODV) Analyst Ratings

Based on 5 analyst ratings
Buy
Strong Buy 20%
Buy 20%
Hold 60%
Sell 0%
Strong Sell 0%

Bulls say

ModivCare Inc. has demonstrated a positive trajectory in its non-emergency medical transportation (NEMT) services, with utilization increasing by 192 basis points to 10.8%. The personal care services (PCS) segment experienced a 3.0% growth in top-line service revenue driven by improved revenue per hour, despite a slight decline in total hours. Furthermore, the company's adjusted EBITDA margin reached 9.4%, reflecting enhanced margins and the potential for operational stability through increased fee-for-service contracting and ongoing efficiency improvements.

Bears say

ModivCare's financial outlook appears negative due to several declining revenue metrics and substantial contract losses impacting its primary business segment. The company is forecasting a 6.7% decline in revenue from its Non-Emergency Medical Transportation (NEMT) segment in 2025, primarily attributed to a $200 million revenue hit from significant contract attrition. Additionally, the Remote Monitoring (RM) segment experienced a 5.3% revenue decline in the recent quarter, exacerbating the overall concerns surrounding the company's financial performance and operating margins, which have notably declined by around 600 basis points to just over 3%.

ModivCare (MODV) has been analyzed by 5 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 20% recommend Buy, 60% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of ModivCare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About ModivCare (MODV) Forecast

Analysts have given ModivCare (MODV) a Buy based on their latest research and market trends.

According to 5 analysts, ModivCare (MODV) has a Buy consensus rating as of Jun 17, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $14.70, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $14.70, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

ModivCare (MODV)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.